iShares Biotechnology ETF (IBB) Price, Holdings, & News

ETF Overview

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Key Stats

• Today's Range: $121.68 to $123.25
• 50-Day Range: $112.02 to $135.31
• 52-Week Range: $107.43 to $150.57
• Volume: 2.20 million shs
• Average Volume: 1.41 million shs
• Market Capitalization: $5.33 billion
• Assets Under Management: $5.23 billion
• Dividend Yield: 0.31%
• Net Expense Ratio: 0.45%
• Aggregate Rating: Moderate Buy

IBB ETF - Frequently Asked Questions

How have IBB shares performed this year?

iShares Biotechnology ETF's stock was trading at $132.21 on January 1st, 2025. Since then, IBB stock has decreased by 7.8% and is now trading at $121.91.
View the best growth stocks for 2025 here.

When did iShares Biotechnology ETF's stock split?

iShares Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Who are iShares Biotechnology ETF's major shareholders?

Top institutional shareholders of iShares Biotechnology ETF include Citigroup Inc. (7.33%), BNP Paribas Financial Markets (2.09%), Royal Bank of Canada (1.75%) and Commerce Bank (1.37%).

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that iShares Biotechnology ETF investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and iShares Micro-Cap ETF (IWC).

Fund Details

• Issuer: iShares
• Fund Name: iShares Biotechnology ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NASDAQ
• Current Symbol: NASDAQ:IBB
• Inception Date: 2/5/2001
• Fund Manager: Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
• Web: N/A
• Phone: N/A

Fund Focus

• Asset Class: Equity
• Benchmark: NYSE Biotechnology Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 264

Fund Statistics

• Assets Under Management: $5.23 billion
• Average Daily Volume: $2.00 million
• Discount/Premium: -0.03%

Administrator, Advisor and Custodian

• Administrator: J.P. Morgan Chase Bank, N.A.
• Advisor: BlackRock Fund Advisors
• Custodian: JPMorgan Chase Bank, N.A.
• Distributor: BlackRock Investments, LLC
• Transfer Agent: J.P. Morgan Chase Bank, N.A.
• Trustee: N/A
• Lead Market Maker: Latour Trading

Options

• Optionable: Optionable
• Options Volume: 1,655
• Put Options: 938
• Call Options: 717
• Short Interest: 11,120,000 shs

Miscellaneous

• Outstanding Shares: 43,750,000
• Beta: 0.84
• Creation Unit: 50,000
• Creation Fee: $614.00